---
title: "BEACON PHARMACEUTICALS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/d8ba152d-ddef-5eb9-b6e3-22d685c277d5
json: https://whiteintel.dev/api/public/dossier/d8ba152d-ddef-5eb9-b6e3-22d685c277d5
identifier: oo:GB-COH-03953215
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BEACON PHARMACEUTICALS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-03953215`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/d8ba152d-ddef-5eb9-b6e3-22d685c277d5  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/d8ba152d-ddef-5eb9-b6e3-22d685c277d5  

## Ownership & control

### Owners / controllers

- **KENT PHARMACEUTICALS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/615fba5e-6e2b-5cb1-9ceb-430d0406ac93
- **KENT PHARMACEUTICALS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/615fba5e-6e2b-5cb1-9ceb-430d0406ac93

### UBO chain (walk to the ultimate owner)

A **20-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `03953215`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2000-03-21
- **Registered office:** 2nd Floor, Connect 38 1 Dover Place, Ashford, Kent, TN23 1FB, England
- **SIC:** 21200

### Officers

- JAMES, Kevin — director · British · appointed 2022-03-23
- PETERSEN, Terry John — director · British · appointed 2024-07-15
- SHORT, Joan — secretary · British · appointed 2000-03-21 · resigned 2012-02-23
- COSTIGAN, Conor Francis — director · Irish · appointed 2014-11-27 · resigned 2019-09-16
- DASGUPTA, Debashis — director · British · appointed 2019-09-16 · resigned 2022-03-22
- DEACON, Leslie Robert — director · Irish · appointed 2014-11-27 · resigned 2019-09-16
- KEENAN, Harry — director · Irish · appointed 2015-05-01 · resigned 2019-09-16
- MCEVOY, Redmond — director · Irish · appointed 2014-11-27 · resigned 2019-09-16
- SHORT, Joan Ann — director · British · appointed 2009-08-25 · resigned 2012-02-23
- SHORT, Steven, Dr — director · British · appointed 2000-03-21 · resigned 2014-11-27
- WRIGHT, David — director · Irish · appointed 2019-09-16 · resigned 2024-07-15

### Beneficial owners (Persons with Significant Control)

- [Kent Pharmaceuticals Limited](https://whiteintel.dev/entity/615fba5e-6e2b-5cb1-9ceb-430d0406ac93) — 75–100% shares · corporate PSC · United Kingdom — since 2016-06-21

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/03953215
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/03953215

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **BEACON PHARMACEUTICALS LIMITED** — https://whiteintel.dev/entity/d8ba152d-ddef-5eb9-b6e3-22d685c277d5 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BEACON PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/d8ba152d-ddef-5eb9-b6e3-22d685c277d5 · Structured JSON: https://whiteintel.dev/api/public/dossier/d8ba152d-ddef-5eb9-b6e3-22d685c277d5._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._